Back to Search
Start Over
Construction and Validation of Necroptosis Risk-Scoring Signature in Lung Adenocarcinoma
- Source :
- Indian Journal of Pharmaceutical Sciences. 84
- Publication Year :
- 2022
- Publisher :
- Indian Pharmaceutical Association - IPA, 2022.
Details
- Volume :
- 84
- Database :
- OpenAIRE
- Journal :
- Indian Journal of Pharmaceutical Sciences
- Accession number :
- edsair.doi...........043309cc0ced2ad13703e1b7614a1f96